Metastatic Colorectal Cancers Withdrawn Phase 1 / 2 Trials for Pembrolizumab (DB09037)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Withdrawn1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03182894Epacadostat in Combination With Pembrolizumab and Azacitidine in Subjects With Metastatic Colorectal CancerTreatment